The Medicines’ Serialization project which means the implementation of the Falsified Medicines Directive 2011/62/EU has as a foundation patient’s safety through medicines’ safety.
All stakeholders are involved in the continuous improvement of the National Medicines Verification System (NMVS) and the importance of an open and collaborative communication is greatly acknowledged throughout this process.
The National Agency for Medicines and Medical Devices (ANMDMR) outlines the importance of raising awareness among End-Users of their obligations under the Delegated Regulation 2016/161.
You are kindly invited to click on the following link Serialization – ANMDMR in order to view the Agency’s communication on the inspections that will follow related to the compliance of the legal obligations.
